Anticoagulation in valvar heart disease: new aspects and management during non-cardiac surgery.
作者信息
Gohlke-Bärwolf C
机构信息
Herz Zentrum, Bad Krozingen, Germany. h.gohlke@t-online
出版信息
Heart. 2000 Nov;84(5):567-72. doi: 10.1136/heart.84.5.567.
Abstract
摘要
相似文献
1
Anticoagulation in valvar heart disease: new aspects and management during non-cardiac surgery.心脏瓣膜病的抗凝治疗：非心脏手术期间的新情况与管理
Heart. 2000 Nov;84(5):567-72. doi: 10.1136/heart.84.5.567.
2
Perioperative anticoagulation: looking through heparin window.围手术期抗凝：透过肝素之窗审视
JAAPA. 2004 Jun;17(6):21-5; quiz 33-4.
3
Anticoagulation bridging around device surgery: compliance with guidelines.器械手术围手术期的抗凝桥接治疗：指南遵循情况
Pacing Clin Electrophysiol. 2012 Dec;35(12):1480-6. doi: 10.1111/j.1540-8159.2012.03516.x. Epub 2012 Sep 14.
4
Managing oral anticoagulant therapy in patients with mechanical heart valves undergoing elective surgery: results of a survey conducted among Italian physicians.对接受择期手术的机械心脏瓣膜患者进行口服抗凝治疗的管理：一项针对意大利医生的调查结果
Blood Coagul Fibrinolysis. 2004 Oct;15(8):623-8. doi: 10.1097/00001721-200412000-00001.
5
The current status of bridging anticoagulation.桥接抗凝的现状
Br J Haematol. 2014 Mar;164(5):619-29. doi: 10.1111/bjh.12644. Epub 2013 Nov 13.
6
Bridging anticoagulation for interruption of warfarin in a patient with atrial fibrillation.房颤患者华法林中断治疗期间的桥接抗凝
CMAJ. 2016 Mar 15;188(5):361-362. doi: 10.1503/cmaj.150867. Epub 2015 Dec 22.
7
Guidelines on oral anticoagulation (warfarin): third edition--2005 update.口服抗凝治疗（华法林）指南：第三版——2005年更新
Br J Haematol. 2006 Feb;132(3):277-85. doi: 10.1111/j.1365-2141.2005.05856.x.
8
A practical approach for bridging anticoagulation after mechanical heart valve replacement.机械心脏瓣膜置换术后桥接抗凝的实用方法。
J Heart Valve Dis. 2008 May;17(3):335-42.
9
eComment: Are low molecular weight heparin effective in mechanical valve prosthesis anticoagulation during pregnancy?电子评论：低分子量肝素在孕期机械瓣膜置换术后抗凝治疗中是否有效？
Interact Cardiovasc Thorac Surg. 2010 Jan;10(1):118-9. doi: 10.1510/icvts.2009.220806B.
10
Anticoagulation of pregnant women with mechanical heart valves using low-molecular-weight heparin.使用低分子量肝素对患有机械心脏瓣膜的孕妇进行抗凝治疗。
Arch Intern Med. 2003;163(22):2788-9. doi: 10.1001/archinte.163.22.2788-b.
引用本文的文献
1
[Current recommendations for prevention of thromboembolic events in patients with heart valve prostheses].[心脏瓣膜置换术后患者血栓栓塞事件预防的现行推荐意见]
Z Kardiol. 2001 Dec;90(Suppl 6):112-7. doi: 10.1007/s003920170018.
2
Anesthetic management of a patient with prosthetic heart valve for non-cardiac surgery: A case report.人工心脏瓣膜患者非心脏手术的麻醉管理：一例报告
Cases J. 2008 Sep 30;1(1):196. doi: 10.1186/1757-1626-1-196.
3
Thrombosis of prosthetic heart valves: diagnosis and therapeutic considerations.人工心脏瓣膜血栓形成：诊断与治疗考量
Heart. 2007 Jan;93(1):137-42. doi: 10.1136/hrt.2005.071183.
4
Management and follow up of prosthetic heart valves.人工心脏瓣膜的管理与随访
Heart. 2004 Jul;90(7):818-24. doi: 10.1136/hrt.2003.025049.
5
Experience with enoxaparin in patients with mechanical heart valves who must withhold acenocumarol.依诺肝素在必须停用醋硝香豆素的机械心脏瓣膜患者中的应用经验。
Heart. 2003 May;89(5):527-30. doi: 10.1136/heart.89.5.527.
6
Present treatment options for atrial fibrillation.心房颤动的现有治疗方案。
Postgrad Med J. 2003 Feb;79(928):67-73. doi: 10.1136/pmj.79.928.67.
7
Choice of heart valve prosthesis.心脏瓣膜假体的选择。
Heart. 2002 Jun;87(6):583-9. doi: 10.1136/heart.87.6.583.
8
The medical management of valvar heart disease.心脏瓣膜病的药物治疗
Heart. 2002 Apr;87(4):395-400. doi: 10.1136/heart.87.4.395.
9
Valve disease: Surgery of valve disease: late results and late complications.瓣膜疾病：瓣膜疾病的外科治疗：远期结果与远期并发症
Heart. 2001 Dec;86(6):715-21. doi: 10.1136/heart.86.6.715.
10
Fulminant thrombosis of mechanical mitral valve prosthesis.机械二尖瓣人工瓣膜的暴发性血栓形成
Heart. 2001 Nov;86(5):E16. doi: 10.1136/heart.86.5.e16.
本文引用的文献
1
Low molecular weight heparin after mechanical heart valve replacement.机械心脏瓣膜置换术后应用低分子量肝素
Circulation. 2000 Mar 14;101(10):1083-6. doi: 10.1161/01.cir.101.10.1083.
2
3
A structured teaching and self-management program for patients receiving oral anticoagulation: a randomized controlled trial. Working Group for the Study of Patient Self-Management of Oral Anticoagulation.一项针对接受口服抗凝治疗患者的结构化教学与自我管理项目：一项随机对照试验。口服抗凝治疗患者自我管理研究工作组。
JAMA. 1999 Jan 13;281(2):145-50. doi: 10.1001/jama.281.2.145.
4
ACC/AHA guidelines for the management of patients with valvular heart disease. A report of the American College of Cardiology/American Heart Association. Task Force on Practice Guidelines (Committee on Management of Patients with Valvular Heart Disease).美国心脏病学会/美国心脏协会瓣膜性心脏病患者管理指南。美国心脏病学会/美国心脏协会报告。实践指南工作组（瓣膜性心脏病患者管理委员会）。
J Am Coll Cardiol. 1998 Nov;32(5):1486-588. doi: 10.1016/s0735-1097(98)00454-9.
5
Dental surgery in anticoagulated patients.抗凝患者的牙科手术。
Arch Intern Med. 1998;158(15):1610-6. doi: 10.1001/archinte.158.15.1610.
6
Correction of excessive anticoagulation with low-dose oral vitamin K1.小剂量口服维生素K1纠正过度抗凝
Ann Intern Med. 1997 Jun 15;126(12):959-62. doi: 10.7326/0003-4819-126-12-199706150-00005.
7
AREVA: multicenter randomized comparison of low-dose versus standard-dose anticoagulation in patients with mechanical prosthetic heart valves.阿海珐公司：机械人工心脏瓣膜患者低剂量与标准剂量抗凝治疗的多中心随机对照研究
Circulation. 1996 Nov 1;94(9):2107-12. doi: 10.1161/01.cir.94.9.2107.
8
Guidelines for prevention of thromboembolic events in valvular heart disease. Study Group of the Working Group on Valvular Heart Disease of the European Society of Cardiology.心脏瓣膜病血栓栓塞事件预防指南。欧洲心脏病学会心脏瓣膜病工作组研究组。
Eur Heart J. 1995 Oct;16(10):1320-30. doi: 10.1093/oxfordjournals.eurheartj.a060739.
9
A comparison of aspirin with placebo in patients treated with warfarin after heart-valve replacement.心脏瓣膜置换术后接受华法林治疗的患者中阿司匹林与安慰剂的比较。
N Engl J Med. 1993 Aug 19;329(8):524-9. doi: 10.1056/NEJM199308193290802.
10
Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses.机械心脏瓣膜置换术后患者的血栓栓塞和出血并发症
Circulation. 1994 Feb;89(2):635-41. doi: 10.1161/01.cir.89.2.635.
Zotero 插件